Apellis is a global biopharmaceutical company that develops life-changing therapies. By pioneering targeted C3 therapies, we aim to treat diseases that are driven by excessive activation of the complement cascade, including those within hematology, ophthalmology, and nephrology.
Domain | apellis.com |
---|---|
Homepage URL | https://apellis.com |
Sprache | englisch |